| Product Code: ETC7658553 | Publication Date: Sep 2024 | Updated Date: Apr 2026 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Shubham Padhi | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The Israel patient-derived xenograft (PDX) models import market saw a shift in concentration levels, moving from moderate to high in 2024. Top exporting countries to Israel in 2024 include Switzerland, Netherlands, Belgium, Germany, and the USA. The compound annual growth rate (CAGR) from 2020 to 2024 was strong at 8.91%, indicating a healthy market expansion. However, there was a slight decline in growth rate from 2023 to 2024, with a -4.56% change. These trends suggest a dynamic and evolving landscape for PDX model imports in Israel.

1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Israel Patient Derived Xenograft (PDX) Models Market Overview |
3.1 Israel Country Macro Economic Indicators |
3.2 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, 2022 & 2032F |
3.3 Israel Patient Derived Xenograft (PDX) Models Market - Industry Life Cycle |
3.4 Israel Patient Derived Xenograft (PDX) Models Market - Porter's Five Forces |
3.5 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Type, 2022 & 2032F |
3.6 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Tumor Type, 2022 & 2032F |
3.7 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Application, 2022 & 2032F |
3.8 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By Technique, 2022 & 2032F |
3.9 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume Share, By End User, 2022 & 2032F |
4 Israel Patient Derived Xenograft (PDX) Models Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Rising prevalence of cancer in Israel |
4.2.2 Increasing research activities in oncology and personalized medicine |
4.2.3 Growing focus on precision medicine and targeted therapies |
4.3 Market Restraints |
4.3.1 High costs associated with developing and maintaining patient-derived xenograft (PDX) models |
4.3.2 Ethical concerns related to the use of animals in research |
4.3.3 Limited availability of skilled professionals for PDX model development |
5 Israel Patient Derived Xenograft (PDX) Models Market Trends |
6 Israel Patient Derived Xenograft (PDX) Models Market, By Types |
6.1 Israel Patient Derived Xenograft (PDX) Models Market, By Type |
6.1.1 Overview and Analysis |
6.1.2 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Type, 2022 - 2032F |
6.1.3 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Mice Models, 2022 - 2032F |
6.1.4 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Rat Models, 2022 - 2032F |
6.2 Israel Patient Derived Xenograft (PDX) Models Market, By Tumor Type |
6.2.1 Overview and Analysis |
6.2.2 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Gastrointestinal Tumor Models, 2022 - 2032F |
6.2.3 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Lung Tumor Models, 2022 - 2032F |
6.2.4 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Haematological Tumor Models, 2022 - 2032F |
6.3 Israel Patient Derived Xenograft (PDX) Models Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Preclinical Drug Development, 2022 - 2032F |
6.3.3 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Precision Medicine, 2022 - 2032F |
6.3.4 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Co-Clinical Trials, 2022 - 2032F |
6.3.5 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Basic Cancer Research, 2022 - 2032F |
6.3.6 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Biomarker Analysis, 2022 - 2032F |
6.3.7 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Oncology Research, 2022 - 2032F |
6.4 Israel Patient Derived Xenograft (PDX) Models Market, By Technique |
6.4.1 Overview and Analysis |
6.4.2 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Heterotopic Implantation, 2022 - 2032F |
6.4.3 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Orthotropic Implantation, 2022 - 2032F |
6.5 Israel Patient Derived Xenograft (PDX) Models Market, By End User |
6.5.1 Overview and Analysis |
6.5.2 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Academic and Research Organizations, 2022 - 2032F |
6.5.3 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Contract Research Organizations, 2022 - 2032F |
6.5.4 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Pharmaceutical and Biotechnological Companies, 2022 - 2032F |
6.5.5 Israel Patient Derived Xenograft (PDX) Models Market Revenues & Volume, By Others, 2022 - 2032F |
7 Israel Patient Derived Xenograft (PDX) Models Market Import-Export Trade Statistics |
7.1 Israel Patient Derived Xenograft (PDX) Models Market Export to Major Countries |
7.2 Israel Patient Derived Xenograft (PDX) Models Market Imports from Major Countries |
8 Israel Patient Derived Xenograft (PDX) Models Market Key Performance Indicators |
8.1 Average time to develop a PDX model |
8.2 Success rate of engraftment of patient tumor samples in PDX models |
8.3 Number of collaborative research projects utilizing PDX models |
9 Israel Patient Derived Xenograft (PDX) Models Market - Opportunity Assessment |
9.1 Israel Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Type, 2022 & 2032F |
9.2 Israel Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Tumor Type, 2022 & 2032F |
9.3 Israel Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Application, 2022 & 2032F |
9.4 Israel Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By Technique, 2022 & 2032F |
9.5 Israel Patient Derived Xenograft (PDX) Models Market Opportunity Assessment, By End User, 2022 & 2032F |
10 Israel Patient Derived Xenograft (PDX) Models Market - Competitive Landscape |
10.1 Israel Patient Derived Xenograft (PDX) Models Market Revenue Share, By Companies, 2025 |
10.2 Israel Patient Derived Xenograft (PDX) Models Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here